Selected research
Industry Research
Colchicine Industry Research Report 2026
Market perspective
The global Colchicine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Colchicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Colchicine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Colchicine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Colchicine include Yunnan Plant Medicine, Xishuangbanna Pharmaceutical, Takeda Pharmaceuticals, Tonghua Limin, Kunming Pharmaceutical, Beijing Jialin Pharmaceutical, Yunnan Shan State, Wockhardt and West-Ward, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Colchicine market in terms of revenue (US$ million) and, where applicable, sales volume (tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Colchicine Market by Company
Yunnan Plant Medicine
Xishuangbanna Pharmaceutical
Takeda Pharmaceuticals
Tonghua Limin
Kunming Pharmaceutical
Beijing Jialin Pharmaceutical
Yunnan Shan State
Wockhardt
West-Ward
Rhea Pharmaceutical
Prasco
Odan Laboratories
Medinova
Hikma
Guangdong Pedi
Excellium Pharmaceutical
Cipla
Colchicine Segment by Type
Tablet
Oral Solution
Colchicine Segment by Application
Acute Gout
Chronic Gout
Other Conditions
Colchicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colchicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Colchicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colchicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Colchicine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Colchicine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Colchicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Oral Solution
Applications
- Acute Gout
- Chronic Gout
- Other Conditions
Companies covered
- Yunnan Plant Medicine
- Xishuangbanna Pharmaceutical
- Takeda Pharmaceuticals
- Tonghua Limin
- Kunming Pharmaceutical
- Beijing Jialin Pharmaceutical
- Yunnan Shan State
- Wockhardt
- West-Ward
- Rhea Pharmaceutical
- Prasco
- Odan Laboratories
- Medinova
- Hikma
- Guangdong Pedi
- Excellium Pharmaceutical
- Cipla
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Colchicine Market Size (2021-2032)
- 2.2.2 Global Colchicine Sales (2021-2032)
- 2.2.3 Global Colchicine Market Average Price (2021-2032)
- 2.3 Colchicine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablet
- 2.3.3 Oral Solution
- 2.4 Colchicine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Acute Gout
- 2.4.3 Chronic Gout
- 2.4.4 Other Conditions
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Colchicine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Colchicine Sales (tons) of Manufacturers (2021-2026)
- 3.3 Global Colchicine Revenue of Manufacturers (2021-2026)
- 3.4 Global Colchicine Average Price by Manufacturers (2021-2026)
- 3.5 Global Colchicine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Colchicine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Colchicine, Product Type & Application
- 3.8 Global Manufacturers of Colchicine, Established Date
- 3.9 Global Colchicine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yunnan Plant Medicine
- 4.1.1 Yunnan Plant Medicine Company Information
- 4.1.2 Yunnan Plant Medicine Business Overview
- 4.1.3 Yunnan Plant Medicine Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yunnan Plant Medicine Colchicine Product Portfolio
- 4.1.5 Yunnan Plant Medicine Recent Developments
- 4.2 Xishuangbanna Pharmaceutical
- 4.2.1 Xishuangbanna Pharmaceutical Company Information
- 4.2.2 Xishuangbanna Pharmaceutical Business Overview
- 4.2.3 Xishuangbanna Pharmaceutical Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Xishuangbanna Pharmaceutical Colchicine Product Portfolio
- 4.2.5 Xishuangbanna Pharmaceutical Recent Developments
- 4.3 Takeda Pharmaceuticals
- 4.3.1 Takeda Pharmaceuticals Company Information
- 4.3.2 Takeda Pharmaceuticals Business Overview
- 4.3.3 Takeda Pharmaceuticals Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Takeda Pharmaceuticals Colchicine Product Portfolio
- 4.3.5 Takeda Pharmaceuticals Recent Developments
- 4.4 Tonghua Limin
- 4.4.1 Tonghua Limin Company Information
- 4.4.2 Tonghua Limin Business Overview
- 4.4.3 Tonghua Limin Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Tonghua Limin Colchicine Product Portfolio
- 4.4.5 Tonghua Limin Recent Developments
- 4.5 Kunming Pharmaceutical
- 4.5.1 Kunming Pharmaceutical Company Information
- 4.5.2 Kunming Pharmaceutical Business Overview
- 4.5.3 Kunming Pharmaceutical Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Kunming Pharmaceutical Colchicine Product Portfolio
- 4.5.5 Kunming Pharmaceutical Recent Developments
- 4.6 Beijing Jialin Pharmaceutical
- 4.6.1 Beijing Jialin Pharmaceutical Company Information
- 4.6.2 Beijing Jialin Pharmaceutical Business Overview
- 4.6.3 Beijing Jialin Pharmaceutical Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Beijing Jialin Pharmaceutical Colchicine Product Portfolio
- 4.6.5 Beijing Jialin Pharmaceutical Recent Developments
- 4.7 Yunnan Shan State
- 4.7.1 Yunnan Shan State Company Information
- 4.7.2 Yunnan Shan State Business Overview
- 4.7.3 Yunnan Shan State Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Yunnan Shan State Colchicine Product Portfolio
- 4.7.5 Yunnan Shan State Recent Developments
- 4.8 Wockhardt
- 4.8.1 Wockhardt Company Information
- 4.8.2 Wockhardt Business Overview
- 4.8.3 Wockhardt Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Wockhardt Colchicine Product Portfolio
- 4.8.5 Wockhardt Recent Developments
- 4.9 West-Ward
- 4.9.1 West-Ward Company Information
- 4.9.2 West-Ward Business Overview
- 4.9.3 West-Ward Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 West-Ward Colchicine Product Portfolio
- 4.9.5 West-Ward Recent Developments
- 4.10 Rhea Pharmaceutical
- 4.10.1 Rhea Pharmaceutical Company Information
- 4.10.2 Rhea Pharmaceutical Business Overview
- 4.10.3 Rhea Pharmaceutical Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Rhea Pharmaceutical Colchicine Product Portfolio
- 4.10.5 Rhea Pharmaceutical Recent Developments
- 4.11 Prasco
- 4.11.1 Prasco Company Information
- 4.11.2 Prasco Business Overview
- 4.11.3 Prasco Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Prasco Colchicine Product Portfolio
- 4.11.5 Prasco Recent Developments
- 4.12 Odan Laboratories
- 4.12.1 Odan Laboratories Company Information
- 4.12.2 Odan Laboratories Business Overview
- 4.12.3 Odan Laboratories Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Odan Laboratories Colchicine Product Portfolio
- 4.12.5 Odan Laboratories Recent Developments
- 4.13 Medinova
- 4.13.1 Medinova Company Information
- 4.13.2 Medinova Business Overview
- 4.13.3 Medinova Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Medinova Colchicine Product Portfolio
- 4.13.5 Medinova Recent Developments
- 4.14 Hikma
- 4.14.1 Hikma Company Information
- 4.14.2 Hikma Business Overview
- 4.14.3 Hikma Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Hikma Colchicine Product Portfolio
- 4.14.5 Hikma Recent Developments
- 4.15 Guangdong Pedi
- 4.15.1 Guangdong Pedi Company Information
- 4.15.2 Guangdong Pedi Business Overview
- 4.15.3 Guangdong Pedi Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Guangdong Pedi Colchicine Product Portfolio
- 4.15.5 Guangdong Pedi Recent Developments
- 4.16 Excellium Pharmaceutical
- 4.16.1 Excellium Pharmaceutical Company Information
- 4.16.2 Excellium Pharmaceutical Business Overview
- 4.16.3 Excellium Pharmaceutical Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Excellium Pharmaceutical Colchicine Product Portfolio
- 4.16.5 Excellium Pharmaceutical Recent Developments
- 4.17 Cipla
- 4.17.1 Cipla Company Information
- 4.17.2 Cipla Business Overview
- 4.17.3 Cipla Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Cipla Colchicine Product Portfolio
- 4.17.5 Cipla Recent Developments
5 Global Colchicine Market Scenario by Region
- 5.1 Global Colchicine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Colchicine Sales by Region: 2021-2032
- 5.2.1 Global Colchicine Sales by Region: 2021-2026
- 5.2.2 Global Colchicine Sales by Region: 2027-2032
- 5.3 Global Colchicine Revenue by Region: 2021-2032
- 5.3.1 Global Colchicine Revenue by Region: 2021-2026
- 5.3.2 Global Colchicine Revenue by Region: 2027-2032
- 5.4 North America Colchicine Market Facts & Figures by Country
- 5.4.1 North America Colchicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Colchicine Sales by Country (2021-2032)
- 5.4.3 North America Colchicine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Colchicine Market Facts & Figures by Country
- 5.5.1 Europe Colchicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Colchicine Sales by Country (2021-2032)
- 5.5.3 Europe Colchicine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Colchicine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Colchicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Colchicine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Colchicine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Colchicine Market Facts & Figures by Country
- 5.7.1 South America Colchicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Colchicine Sales by Country (2021-2032)
- 5.7.3 South America Colchicine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Colchicine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Colchicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Colchicine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Colchicine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Colchicine Sales by Type (2021-2032)
- 6.1.1 Global Colchicine Sales by Type (2021-2032) & (tons)
- 6.1.2 Global Colchicine Sales Market Share by Type (2021-2032)
- 6.2 Global Colchicine Revenue by Type (2021-2032)
- 6.2.1 Global Colchicine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Colchicine Revenue Market Share by Type (2021-2032)
- 6.3 Global Colchicine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Colchicine Sales by Application (2021-2032)
- 7.1.1 Global Colchicine Sales by Application (2021-2032) & (tons)
- 7.1.2 Global Colchicine Sales Market Share by Application (2021-2032)
- 7.2 Global Colchicine Revenue by Application (2021-2032)
- 7.2.1 Global Colchicine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Colchicine Revenue Market Share by Application (2021-2032)
- 7.3 Global Colchicine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Colchicine Value Chain Analysis
- 8.1.1 Colchicine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Colchicine Production Mode & Process
- 8.2 Colchicine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Colchicine Distributors
- 8.2.3 Colchicine Customers
9 Global Colchicine Analyzing Market Dynamics
- 9.1 Colchicine Industry Trends
- 9.2 Colchicine Industry Drivers
- 9.3 Colchicine Industry Opportunities and Challenges
- 9.4 Colchicine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst